Artra Group
6029
Daiwa Cycle
5888
Business Coach
9562
D. Western Therapeutics Institute
4576
Asiro
7378
(FY)Jan 31, 2024 | (FY)Jan 31, 2023 | (FY)Jan 31, 2022 | (FY)Jan 31, 2021 | (FY)Jan 31, 2020 | (FY)Jan 31, 2019 | (FY)Jan 31, 2018 | (FY)Jan 31, 2017 | (FY)Jan 31, 2016 | (FY)Jan 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 665.63%10.71B | 76.86%-1.89B | -309.42%-8.18B | 170.64%3.91B | 62.98%1.44B | -72.22%886M | -53.74%3.19B | 256.04%6.89B | 147.38%1.94B | -39.41%-4.09B |
Net profit before non-cash adjustment | 87.69%8.21B | 73.08%4.37B | 145.72%2.53B | -53.67%1.03B | 44.84%2.22B | 213.93%1.53B | -63.61%488M | 9.74%1.34B | -54.56%1.22B | 28.23%2.69B |
Total adjustment of non-cash items | -13,210.26%-5.11B | 111.27%39M | -208.13%-346M | -67.01%320M | 547.00%970M | 70.03%-217M | -197.18%-724M | 494.18%745M | 84.13%-189M | -47.77%-1.19B |
-Depreciation and amortization | 4.53%254M | 0.41%243M | -14.49%242M | 2.91%283M | 26.73%275M | -3.98%217M | -9.24%226M | 4.18%249M | 10.14%239M | 13.02%217M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --141M | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 103.25%30M | -2,351.22%-923M |
-Share of associates | ---5.06B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | -103.96%-4M | 130.79%101M | -8.25%-328M | -169.34%-303M | 230.45%437M | -1.82%-335M | -422.22%-329M | 83.06%-63M | -4.20%-372M | -127.39%-357M |
-Net exchange gains and losses | -227.68%-367M | -296.49%-112M | 319.23%57M | ---26M | --0 | 82.35%-3M | -70.00%-17M | -128.57%-10M | -76.03%35M | 603.45%146M |
-Remuneration paid in stock | 20.00%48M | -29.82%40M | 11.76%57M | 88.89%51M | -62.50%27M | --72M | ---- | ---- | ---- | ---- |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -101.29%-12M | --927M |
-Other non-cash items | 104.72%11M | 37.70%-233M | -218.73%-374M | 36.36%315M | 237.50%231M | 72.19%-168M | -206.15%-604M | 327.60%569M | 79.18%-250M | -40.80%-1.2B |
Changes in working capital | 220.81%7.62B | 39.17%-6.31B | -505.28%-10.37B | 246.51%2.56B | -304.17%-1.75B | -112.62%-432M | -28.77%3.42B | 432.34%4.81B | 116.17%903M | -32.26%-5.58B |
-Change in receivables | 366.47%3.18B | 79.54%-1.19B | -303.92%-5.83B | 208.75%2.86B | -1,441.84%-2.63B | -94.07%196M | -14.72%3.31B | 383.67%3.88B | 122.00%802M | 39.38%-3.65B |
-Change in inventory | 234.32%4.71B | 53.43%-3.51B | -860.30%-7.53B | 295.65%990M | 61.37%-506M | -350.17%-1.31B | -159.88%-291M | -85.21%486M | 461.89%3.29B | 42.96%-908M |
-Change in payables | 93.74%-123M | -168.78%-1.97B | 380.65%2.86B | -152.77%-1.02B | 184.51%1.93B | 340.26%678M | -61.50%154M | 112.55%400M | -219.44%-3.19B | -129.61%-998M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 109.09%3M | -353.85%-33M |
-Provision for loans, leases and other losses | -140.90%-146M | 164.44%357M | 149.27%135M | 49.17%-274M | -13,575.00%-539M | -98.42%4M | 283.33%253M | --66M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---24M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -115.08%-385M | -103.41%-179M | -66.04%-88M | -5,200.00%-53M | -1M | |||||
Interest received (cash flow from operating activities) | 522.97%922M | 16.54%148M | -36.82%127M | -12.61%201M | 8.49%230M | -8.23%212M | 21.58%231M | -19.15%190M | -24.19%235M | 27.57%310M |
Tax refund paid | -247.45%-2.18B | -1,081.25%-628M | 106.31%64M | -387.98%-1.02B | 59.14%-208M | -47.11%-509M | 15.40%-346M | 59.18%-409M | 4.75%-1B | -164.99%-1.05B |
Other operating cash inflow (outflow) | 0 | 0 | 76.32%-9M | -1,800.00%-38M | -100.00%-2M | -1M | 0 | 1M | 0 | 0.00%1M |
Operating cash flow | 455.19%9.07B | 68.44%-2.55B | -369.40%-8.09B | 105.26%3B | 148.81%1.46B | -80.87%588M | -53.95%3.07B | 471.00%6.68B | 124.22%1.17B | -56.52%-4.83B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -75.29%-454M | -71.52%-259M | -42.45%-151M | 34.97%-106M | -1.88%-163M | -97.53%-160M | 58.03%-81M | 53.04%-193M | -45.23%-411M | -194.79%-283M |
Net business purchase and sale | ---16.8B | --0 | 79.42%-99M | -6,971.43%-481M | 333.33%7M | ---3M | ---- | ---- | ---- | ---- |
Net investment product transactions | -140.97%-186M | -83.04%454M | -75.32%2.68B | 2,322.95%10.85B | -220.49%-488M | 105.50%405M | -1,857.76%-7.37B | -85.42%419M | -51.24%2.87B | 5,974.23%5.89B |
Advance cash and loans provided to other parties | ---- | ---60M | --0 | ---- | -122.22%-220M | -37.50%-99M | -118.18%-72M | ---33M | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | --22M | ---- | ---- | ---- | ---- | 0.00%99M | --99M | ---- | ---- | ---- |
Dividends received (cash flow from investment activities) | 84.21%35M | -85.04%19M | 47.67%127M | 273.91%86M | -87.43%23M | 19.61%183M | -9.47%153M | --169M | ---- | ---- |
Net changes in other investments | 275.00%7M | ---4M | ---- | 12.00%84M | -36.44%75M | 293.33%118M | 118.29%30M | -121.55%-164M | 340.82%761M | -118.44%-316M |
Investing cash flow | -11,682.67%-17.37B | -94.13%150M | -75.52%2.55B | 1,461.75%10.43B | -241.07%-766M | 107.50%543M | -3,754.55%-7.24B | -93.86%198M | -39.11%3.22B | 208.63%5.29B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -87.74%1.61B | 182.42%13.14B | -29.85%4.65B | --6.63B | ---- | ---- | ---- | ---- | ---- | ---- |
Net common stock issuance | -100.16%-1M | -88.17%635M | 123.91%5.37B | -2,245,000.00%-22.45B | 0.00%-1M | 50.00%-1M | 99.00%-2M | 77.86%-201M | -90,700.00%-908M | 99.85%-1M |
Increase or decrease of lease financing | 16.67%-25M | 11.76%-30M | 5.56%-34M | -38.46%-36M | ---26M | ---- | ---- | ---- | ---- | ---- |
Cash dividends paid | -28.56%-2.82B | 29.94%-2.2B | -27.46%-3.13B | -43.24%-2.46B | -16.97%-1.72B | -20.05%-1.47B | -42.59%-1.22B | -14.88%-857M | 1.06%-746M | 2.33%-754M |
Net other fund-raising expenses | 0.00%-2M | -111.11%-2M | 220.00%18M | ---15M | ---- | ---- | ---- | ---- | ---- | ---- |
Financing cash flow | -110.73%-1.24B | 68.06%11.55B | 137.50%6.87B | -951.46%-18.33B | -18.73%-1.74B | -19.93%-1.47B | -15.69%-1.22B | 36.03%-1.06B | -119.07%-1.65B | 47.02%-755M |
Net cash flow | ||||||||||
Beginning cash position | 106.77%19.03B | 20.41%9.2B | -38.44%7.64B | -7.45%12.42B | -3.43%13.42B | -28.18%13.89B | 42.91%19.34B | 24.54%13.54B | -1.41%10.87B | -16.66%11.02B |
Current changes in cash | -204.36%-9.55B | 584.58%9.15B | 127.30%1.34B | -367.78%-4.89B | -210.39%-1.05B | 93.74%-337M | -192.62%-5.39B | 112.38%5.82B | 1,047.40%2.74B | 89.66%-289M |
Effect of exchange rate changes | 110.92%734M | 56.05%348M | 448.44%223M | -36.17%-64M | 66.43%-47M | -125.81%-140M | -675.00%-62M | 88.73%-8M | -152.59%-71M | -77.16%135M |
Cash adjustments other than cash changes | -100.30%-1M | 33,200.00%333M | -99.46%1M | 95.74%184M | --94M | ---- | -300.00%-2M | --1M | ---- | ---1M |
End cash Position | -46.30%10.22B | 106.77%19.03B | 20.41%9.2B | -38.44%7.64B | -7.45%12.42B | -3.43%13.42B | -28.18%13.89B | 42.91%19.34B | 24.54%13.54B | -1.41%10.87B |
Free cash flow | 406.22%8.61B | 65.87%-2.81B | -384.60%-8.24B | 122.94%2.9B | 207.09%1.3B | -85.87%423M | -53.83%2.99B | 755.15%6.48B | 114.82%758M | -60.82%-5.11B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |